Rare
lephants
Screener
Toggle theme
Acadia Pharmaceuticals Inc.
ACAD
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Revenue Breakdown
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
30.9%
30.9%
19.1%
FY2025
31.9%
31.9%
25.0%
Download CSV
